1. Home
  2. ACRV vs HKIT Comparison

ACRV vs HKIT Comparison

Compare ACRV & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • HKIT
  • Stock Information
  • Founded
  • ACRV 2018
  • HKIT 1996
  • Country
  • ACRV United States
  • HKIT China
  • Employees
  • ACRV N/A
  • HKIT N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • ACRV Health Care
  • HKIT Technology
  • Exchange
  • ACRV Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • ACRV 47.8M
  • HKIT 54.8M
  • IPO Year
  • ACRV 2022
  • HKIT 2023
  • Fundamental
  • Price
  • ACRV $2.01
  • HKIT $1.99
  • Analyst Decision
  • ACRV Buy
  • HKIT
  • Analyst Count
  • ACRV 6
  • HKIT 0
  • Target Price
  • ACRV $17.75
  • HKIT N/A
  • AVG Volume (30 Days)
  • ACRV 556.9K
  • HKIT 30.0K
  • Earning Date
  • ACRV 11-12-2025
  • HKIT 10-27-2025
  • Dividend Yield
  • ACRV N/A
  • HKIT N/A
  • EPS Growth
  • ACRV N/A
  • HKIT N/A
  • EPS
  • ACRV N/A
  • HKIT N/A
  • Revenue
  • ACRV N/A
  • HKIT $2,904,950.00
  • Revenue This Year
  • ACRV N/A
  • HKIT N/A
  • Revenue Next Year
  • ACRV $805.34
  • HKIT N/A
  • P/E Ratio
  • ACRV N/A
  • HKIT N/A
  • Revenue Growth
  • ACRV N/A
  • HKIT N/A
  • 52 Week Low
  • ACRV $1.05
  • HKIT $1.15
  • 52 Week High
  • ACRV $8.74
  • HKIT $2.08
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 69.57
  • HKIT 68.01
  • Support Level
  • ACRV $1.82
  • HKIT $1.81
  • Resistance Level
  • ACRV $2.00
  • HKIT $1.92
  • Average True Range (ATR)
  • ACRV 0.12
  • HKIT 0.09
  • MACD
  • ACRV 0.01
  • HKIT 0.00
  • Stochastic Oscillator
  • ACRV 87.68
  • HKIT 79.37

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: